Journal of Nuclear Medicine

Explore JNM’s collection of the most influential or frequently cited manuscripts in its 60-year history.

Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition
Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial
JNM Impact Factor 7.887
The Journal of Nuclear Medicine has achieved the highest impact factor ever in its 60-year history, ranking fourth among all medical journals worldwide.

Published Ahead of Print

You have access
Hot Topic, Why will PET be the future of nuclear cardiology?
Marcelo F. Di Carli

Journal of Nuclear Medicine February 19, 2021, jnumed.120.254979; DOI: https://doi.org/10.2967/jnumed.120.254979
You have access
¹⁸F-FDG PET/MRI for staging and interim response assessment in pediatric and adolescent Hodgkin lymphoma: a prospective study with ¹⁸F-FDG PET/CT as reference standard
Martijn Vincent Verhagen, Leon J Menezes, Deena Neriman, Tom A Watson, Shonit Punwani, Stuart A Taylor, Ananth Shankar, Stephen Daw and Paul D Humphries

Journal of Nuclear Medicine February 19, 2021, jnumed.120.260059; DOI: https://doi.org/10.2967/jnumed.120.260059
You have access
From mice to men: the exocrine pancreas does not matter for human GLP-1 receptor imaging
Martin Gotthardt, Lieke Joosten, Theodorus JP Jansen, Maarten Brom, Marti Boss and Stefanie MA Willekens

Journal of Nuclear Medicine February 19, 2021, jnumed.120.259184; DOI: https://doi.org/10.2967/jnumed.120.259184
You have access
Fundamental Statistical Concepts in Clinical Trials and Diagnostic Testing
Stephanie L. Pugh and Pedro Torres-Saavedra

Journal of Nuclear Medicine February 19, 2021, jnumed.120.245654; DOI: https://doi.org/10.2967/jnumed.120.245654
You have access
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted ¹⁸F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide
Katherine A. Zukotynski, Urban Emmenegger, Sebastien Hotte, Anil Kapoor, Wei Fu, Amanda L. Blackford, John Valliant, Francois Benard, Chun K. Kim, Mark C. Markowski, Mario A. Eisenberger, Emmanuel S. Antonarakis, Kenneth J. Pienta, Michael A. Gorin, Matthew Lubanovic, Jihyun Kim, Martin G. Pomper, Steve Y. Cho and Steven P. Rowe

Journal of Nuclear Medicine February 19, 2021, jnumed.120.259069; DOI: https://doi.org/10.2967/jnumed.120.259069
Open Access
Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker
David L Chan, Gary A Ulaner, David A. Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T Li, W. Victoria Lai, Nick Pavlakis, PAUL J ROACH and Dale L. Bailey

Journal of Nuclear Medicine February 12, 2021, jnumed.120.257659; DOI: https://doi.org/10.2967/jnumed.120.257659

About The Journal of Nuclear Medicine

The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.

Main menu

User menu

Search

Published Ahead of Print

Featured Articles

About The Journal of Nuclear Medicine

Current issue

Issue highlights